Arthur A. Levin, Director at Avidity Biosciences, Inc. (RNA), sold 3,744 shares at $28.60 ($107K) on 2025-01-21, disclosed to the SEC on 2025-01-23.
Scheduled sale ($107k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.60 | 1,872 | $54K | 50.0% |
| 2 | $28.60 | 1,872 | $54K | 50.0% |
| Total | $28.60 avg | 3,744 | $107K | 100% |
| Filing → |
| RNA | SELL | 2025-08-08 | $5.1M | — | Filing → |
| RNA | SELL | 2024-11-20 | $280K | — | Filing → |
| RNA | SELL | 2024-10-23 | $233K | — | Filing → |